MGI PHARMA SEES 1Q LOSS

Pharmaceutical firm MGI Pharma Inc. on Thursday said it sees a first-quarter loss that brackets analysts expectations, but predicts revenue will come in lower than Wall Street estimates on less sales of key drug Aloxi.
The Houston Chronicle